Literature DB >> 27518723

Amprenavir : A Viewpoint by Graeme Moyle.

G Moyle1.   

Abstract

Year:  1998        PMID： 27518723     DOI： 10.2165/00003495-199855060-00016

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  5 in total

1.  Viral resistance patterns selected by antiretroviral drugs and their potential to guide treatment choice.

Authors:  G J Moyle
Journal:  Expert Opin Investig Drugs       Date:  1997-08       Impact factor: 6.206

2.  Kinetic characterization of human immunodeficiency virus type-1 protease-resistant variants.

Authors:  S Pazhanisamy; C M Stuver; A B Cullinan; N Margolin; B G Rao; D J Livingston
Journal:  J Biol Chem       Date:  1996-07-26       Impact factor: 5.157

3.  In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors.

Authors:  J H Condra; W A Schleif; O M Blahy; L J Gabryelski; D J Graham; J C Quintero; A Rhodes; H L Robbins; E Roth; M Shivaprakash
Journal:  Nature       Date:  1995-04-06       Impact factor: 49.962

4.  In vitro selection and characterization of human immunodeficiency virus type 1 (HIV-1) isolates with reduced sensitivity to hydroxyethylamino sulfonamide inhibitors of HIV-1 aspartyl protease.

Authors:  J A Partaledis; K Yamaguchi; M Tisdale; E E Blair; C Falcione; B Maschera; R E Myers; S Pazhanisamy; O Futer; A B Cullinan
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

5.  Cross-resistance analysis of human immunodeficiency virus type 1 variants individually selected for resistance to five different protease inhibitors.

Authors:  M Tisdale; R E Myers; B Maschera; N R Parry; N M Oliver; E D Blair
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.